These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 1408152)

  • 21. Lack of transcriptional repression by max homodimers.
    Yin X; Grove L; Prochownik EV
    Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidation of the structural determinants responsible for the specific formation of heterodimeric Mxd1/Max b-HLH-LZ and its binding to E-box sequences.
    Montagne M; Naud JF; Lavigne P
    J Mol Biol; 2008 Feb; 376(1):141-52. PubMed ID: 18155722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward the elucidation of the structural determinants responsible for the molecular recognition between Mad1 and Max.
    Montagne M; Naud JF; McDuff FO; Lavigne P
    Biochemistry; 2005 Sep; 44(38):12860-9. PubMed ID: 16171401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Max and c-Myc/Max DNA-binding activities in cell extracts.
    Littlewood TD; Amati B; Land H; Evan GI
    Oncogene; 1992 Sep; 7(9):1783-92. PubMed ID: 1501888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
    Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
    Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter.
    Lebel R; McDuff FO; Lavigne P; Grandbois M
    Biochemistry; 2007 Sep; 46(36):10279-86. PubMed ID: 17705400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain.
    Ferré-D'Amaré AR; Prendergast GC; Ziff EB; Burley SK
    Nature; 1993 May; 363(6424):38-45. PubMed ID: 8479534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.
    McDuff FO; Naud JF; Montagne M; Sauvé S; Lavigne P
    J Mol Recognit; 2009; 22(4):261-9. PubMed ID: 19189276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.
    Bousset K; Henriksson M; Lüscher-Firzlaff JM; Litchfield DW; Lüscher B
    Oncogene; 1993 Dec; 8(12):3211-20. PubMed ID: 8247525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.
    Beaulieu ME; McDuff FO; Frappier V; Montagne M; Naud JF; Lavigne P
    J Mol Recognit; 2012 Jul; 25(7):414-26. PubMed ID: 22733550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
    Västrik I; Mäkelä TP; Koskinen PJ; Saksela K; Alitalo K
    Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taking myc to the max.
    Turner R
    Nat Struct Biol; 2003 Mar; 10(3):157. PubMed ID: 12605219
    [No Abstract]   [Full Text] [Related]  

  • 34. Assembly of a bZIP-bHLH transcription activation complex: formation of the yeast Cbf1-Met4-Met28 complex is regulated through Met28 stimulation of Cbf1 DNA binding.
    Kuras L; Barbey R; Thomas D
    EMBO J; 1997 May; 16(9):2441-51. PubMed ID: 9171357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
    Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myc and Max proteins possess distinct transcriptional activities.
    Kretzner L; Blackwood EM; Eisenman RN
    Nature; 1992 Oct; 359(6394):426-9. PubMed ID: 1406956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
    Larsson LG; Bahram F; Burkhardt H; Lüscher B
    Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of apoptosis by the c-Myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts.
    Kohlhuber F; Hermeking H; Graessmann A; Eick D
    J Biol Chem; 1995 Dec; 270(48):28797-805. PubMed ID: 7499403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Desbarats L; Gaubatz S; Eilers M
    Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
    Nair SK; Burley SK
    Cell; 2003 Jan; 112(2):193-205. PubMed ID: 12553908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.